Grifols, S.A. American Depositary Receipt (GRFS)
The Schall Law Firm Encourages Affected Investors To Initiate Conversation, Grifols SA Is Under Scrutiny
LOS ANGELES, CA / ACCESSWIRE / July 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.
Grifols SA Under Investigation By The Schall Law Firm Urging Impacted Investors To Start Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.
Grifols SA Under Scrutiny By The Schall Law Firm Encourages Affected Investors To Commence Conversation
LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.
The Schall Law Firm Initiates Investigation Into Allegations Against Grifols SA Urging Impacted Investors To Start Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.
Grifols SA Under Scrutiny By The Schall Law Firm Urging Affected Investors To Initiate Conversation
LOS ANGELES, CA / ACCESSWIRE / July 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.
Probe Into Allegations Against Grifols SA Is Initiated By The Schall Law Firm And Impacted Investors Are Encouraged To Start Dialogue
LOS ANGELES, CA / ACCESSWIRE / July 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.
Investigation Into Claims Against Grifols SA Is Started By The Schall Law Firm And Affected Investors Are Urged To Begin Communication
LOS ANGELES, CA / ACCESSWIRE / July 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.
Grifols Family Shareholders, Brookfield in Talks To Take Firm Private
American depositary receipts (ADRs) of Grifols (GRFS) gained for a second day Tuesday on word Canadian investment manager Brookfield and family member shareholders are in talks to take the Spanish pharmaceutical company private.
Examination Into Allegations Against Grifols SA Is Initiated By The Schall Law Firm And Impacted Investors Are Encouraged To Commence Communication
LOS ANGELES, CA / ACCESSWIRE / July 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grifols, S.A. ("Grifols" or "the Company") (NASDAQ:GRFS) for violations of the securities laws.
GRFS Stock Alert: Grifols Pops 20% on Takeover Interest
Grifols (NASDAQ: GRFS ) stock is jumping on Monday after investors learned that the founding family of the company is considering a takeover offer that would see it go private. The Grifols family is working alongside Brookfield on an offer that would result in a takeover of the business.
Troubled Spanish pharma company Grifols says it may go private for $6 billion
Shares of Grifols were halted on Monday, following news the Spanish blood plasma pharmaceutical company may go private in a deal with Canadian investment managing group Brookfield Capital Partners.
Grifols family, Brookfield eye $6 bln takeover bid for Grifols, report says
The Grifols family and Canadian fund Brookfield are in talks to launch a takeover bid for Spanish drugmaker Grifols that could be worth around 5.5 billion euros ($5.95 billion), business newspaper Cinco Dias reported on Sunday, citing unnamed people familiar with the plans.
